Schedule 13D ownership disclosure

RANI THERAPEUTICS HLDGS INC

Class A Common Stock, $0.0001 par value per share · CUSIP: 753018100

Event date: 2025-10-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Samsara BioCapital, L.P.Reported CIK 0001699737

    Shares: 4,941,239.00 · Class: 5.0%

  • Samsara BioCapital GP, LLCReported CIK 0001888829

    Shares: 4,941,239.00 · Class: 5.0%

  • Samsara Opportunity Fund, L.P.Reported CIK 0002086193

    Shares: 4,941,238.00 · Class: 5.0%

  • Samsara Opportunity Fund GP, LLCReported CIK 0002086456

    Shares: 4,941,238.00 · Class: 5.0%

  • Srinivas AkkarajuReported CIK 0001253170

    Shares: 9,882,477.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001699737-25-000014
Form type
SCHEDULE 13D
Filer
Rani Therapeutics Holdings, Inc.
CIK
CIK 1856725
Filed
Oct 30, 2025
Reporting period
Oct 23, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub